4
Changes in Ownership
Alkermes plc. Filed Acc 0001520262-25-000008
EVP R&D, Chief Medical Officer sold 9,000 shares at $31.53 ($283,776)
- EVP R&D, Chief Medical Officer acquired 5,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Hopkinson Craig C. · EVP R&D, Chief Medical Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-10-15 | Exercise or conversion : show line 1 in the form 10b5-1 | +5,000 | $19.34 | $96,700 | 82,740 | D |
| 2025-10-15 | Sale : show line 2 in the form 10b5-1 | −9,000 | $31.53 | $283,776 | 73,740 | D |
| Open-market sales · 9,000 sh · avg $31.53 · $283,776 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-10-15 | Exercise or conversion : show line 3 in the form 10b5-1 Employee Stock Option (Right to Buy) | −5,000 | 45,104 | D |
Loading xslF345X05/form4.xml…